Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q3 2025 vs. Q2 2025
How the institutions holding Cidara Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 109 | 173 | +64 |
| Shares | 25.9M | 32.5M | +6.58M (+25.4%) |
| Value | $1.26B | $3.11B | +$1.85B (+146.4%) |
New holders (77)
Institutions that held Cidara Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (13)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| TCG Crossover Management, LLC | 1,005,901 | $49.0M |
| Schonfeld Strategic Advisors LLC | 63,223 | $3.08M |
| AXA S.A. | 61,154 | $2.98M |
| Ghisallo Capital Management LLC | 25,000 | $1.22M |
| American Century Companies Inc | 16,221 | $790.1K |
| SummitTX Capital, L.P. | 9,197 | $448.0K |
| XTX Topco Ltd | 8,512 | $414.6K |
| Walleye Capital LLC | 5,900 | $287.4K |
| Clark Wealth Partners | 105 | $5.12K |
| Aster Capital Management (DIFC) Ltd | 57 | $2.78K |
| Dauntless Investment Group, LLC | 54 | $2.63K |
| SBI Securities Co., Ltd. | 9 | $438 |
| Twin Peaks Wealth Advisors, LLC | 1 | $62 |